Evidence map›Paper›PMID 42618753›Full record

ArticleNature neuroscience2026

Cortical thickness changes precede high levels of amyloid by at least 7 years.

James M Roe, William J Jagust, Susan M Landau, Theresa M Harrison, Håkon Grydeland, Maksim Slivka, José-Luis Alatorre-Warren, Pablo F Garrido, Øystein Sørensen, Edvard O S Grødem and 10 more

Abstract read
In one paragraph

Article in Nature neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

James M RoeCenter for Lifespan Changes in Brain and Cognition (LCBC), Department of Psychology, University of Oslo, Oslo, Norway. j.m.roe@psykologi.uio.no.ORCID http://orcid.org/0000-0002-8008-902X
William J JagustDepartment of Neuroscience, University of California, Berkeley, Berkeley, CA, USA.ORCID http://orcid.org/0000-0002-4458-113X
Susan M LandauDepartment of Neuroscience, University of California, Berkeley, Berkeley, CA, USA.
Theresa M HarrisonDepartment of Neuroscience, University of California, Berkeley, Berkeley, CA, USA.
Håkon GrydelandCenter for Lifespan Changes in Brain and Cognition (LCBC), Department of Psychology, University of Oslo, Oslo, Norway.
Maksim SlivkaCenter for Lifespan Changes in Brain and Cognition (LCBC), Department of Psychology, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0009-0001-7563-250X
José-Luis Alatorre-WarrenCenter for Lifespan Changes in Brain and Cognition (LCBC), Department of Psychology, University of Oslo, Oslo, Norway.
Pablo F GarridoCenter for Lifespan Changes in Brain and Cognition (LCBC), Department of Psychology, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0002-6005-7178
Øystein SørensenCenter for Lifespan Changes in Brain and Cognition (LCBC), Department of Psychology, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0003-0724-3542
Edvard O S GrødemCenter for Lifespan Changes in Brain and Cognition (LCBC), Department of Psychology, University of Oslo, Oslo, Norway.
Tyler J WardDepartment of Neuroscience, University of California, Berkeley, Berkeley, CA, USA.
Esten H LeonardsenCenter for Lifespan Changes in Brain and Cognition (LCBC), Department of Psychology, University of Oslo, Oslo, Norway.
Alice MurphyDepartment of Neuroscience, University of California, Berkeley, Berkeley, CA, USA.
JiaQie LeeDepartment of Neuroscience, University of California, Berkeley, Berkeley, CA, USA.
Tormod FladbyDepartment of Neurology, Akershus University Hospital, Lørenskog, Norway.ORCID http://orcid.org/0000-0002-9984-9797
Atle BjørnerudCenter for Lifespan Changes in Brain and Cognition (LCBC), Department of Psychology, University of Oslo, Oslo, Norway.
Kristine B WalhovdCenter for Lifespan Changes in Brain and Cognition (LCBC), Department of Psychology, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0003-1918-1123
Anders M FjellCenter for Lifespan Changes in Brain and Cognition (LCBC), Department of Psychology, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0003-2502-8774
Didac Vidal-Piñeiro *Center for Lifespan Changes in Brain and Cognition (LCBC), Department of Psychology, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0001-9997-9156
Yunpeng Wang *Center for Lifespan Changes in Brain and Cognition (LCBC), Department of Psychology, University of Oslo, Oslo, Norway. yunpeng.wang@medisin.uio.no.ORCID http://orcid.org/0000-0001-9831-1090

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 313440EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 725025University of California, Berkeley | Peder Sather Center for Advanced Study (Peder Sather Center, UC Berkley) Markers of brain activity in early Alzheimer's Disease: The Berkeley-Oslo alliance
6 · The paper itself

Abstract

Alzheimer's disease is now defined by underlying pathology, with elevated amyloid-beta (Aβ) sufficient for diagnosis in the absence of cognitive symptoms. We combined longitudinal magnetic resonance imaging and Aβ positron emission tomography data from three cognitively healthy cohorts to examine cortical thickness trajectories in individuals who later converted to Aβ-positive status, using magnetic resonance images acquired years before conversion. Individuals who subsequently developed elevated Aβ showed a thicker cortex and reduced cortical thinning, detectable up to 7 years before conversion. Many effects persisted after accounting for quantitative Aβ levels, suggesting some cortical thickness changes may be partly independent of Aβ. Differences in cortical thickness and its change showed moderate spatial correspondence with Aβ deposition patterns, and the timing of thickness changes tracked the progression of Aβ accumulation. These findings indicate that cortical thickness alterations can precede positron emission tomography-detectable amyloid positivity by several years, suggesting high amyloid burden may not represent the earliest imaging marker of Alzheimer's disease.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesCerebral CortexAgedAged, 80 and overDisease ProgressionFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMalePositron-Emission TomographyAmyloid beta-Peptides

Identifiers

PMID42618753
PMCPMC13533846

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.